Abstract:Background Long‐term use of antiplatelet agents after acute coronary syndrome in diabetic patients is not well known. Here, we describe antiplatelet use and outcomes in such patients enrolled in the EPICOR Asia (Long‐Term Follow‐up of Antithrombotic Management Patterns in Acute Coronary Syndrome Patients in Asia) registry. Methods and Results EPICOR Asia is a prospective, observational study of 12 922 patients with acute coronary syndrome surviving to discharge, from 8 countries/regions in Asia. The present analysis included 3162 patients with diabetes mellitus (DM) and 9602 patients without DM. The impact of DM on use of antiplatelet agents and events (composite of death, myocardial infarction, and stroke, with or without any revascularization; individual components, and bleeding) was evaluated. Significant baseline differences were seen between patients with DM and patients without DM for age, sex, body mass index, cardiovascular history, angiographic findings, and use of percutaneous coronary intervention. At discharge, ≈90% of patients in each group received dual antiplatelet therapy. At 2‐year follow‐up, more patients with DM tended to still receive dual antiplatelet therapy (60% versus 56%). DM was associated with increased risk from ischemic but not major bleeding events. Independent predictors of the composite end point of death, myocardial infarction, and stroke in patients with DM were age ≥65 years and use of diuretics at discharge. Conclusions Antiplatelet agent use is broadly comparable in patients with DM and patients without DM, although patients with DM are more likely to be on dual antiplatelet therapy at 2 years. Patients with DM are at increased risk of ischemic events, suggesting an unmet need for improved antithrombotic treatment. Registration URL: https://www.clinicaltrials.gov ; Unique identifier: NCT01361386. Nonstandard Abbreviations and Acronyms DAPT dual antiplatelet therapy DM diabetes mellitus EPICOR Long‐Term Follow‐up of Antithrombotic Management Patterns in Acute Coronary Syndrome Patients PoCE patient‐oriented composite end point Clinical Perspective What Is New? Among patients surviving an acute coronary syndrome, ≈90% of both patients with diabetes mellitus (DM) and patients without DM were discharged on dual antiplatelet therapy, but somewhat more patients with DM than patients without DM were on dual antiplatelet therapy at 2 years after discharge (60% versus 56%). Although DM was associated with increased risk of ischemic events during follow‐up, there was minimal impact on risk of major bleeding. Multivariable analysis showed that independent predictors of the composite end point of death, myocardial infarction, and stroke in patients with DM were older age (≥65 years) and use of diuretics at discharge. What Are the Clinical Implications? Despite a higher rate of dual antiplatelet therapy use in patients with DM than patients without DM at 2 years after an acute coronary syndrome, patients with DM were at increased risk of ischemic but not bleeding events, suggesting an unmet need for improved antithrombotic treatment. According to the International Diabetes Federation, in 2015, there were ≈415 million patients worldwide aged 20 to 79 with diabetes mellitus (DM), along with a further 193 million undiagnosed cases. 1 Type 2 DM accounts for up to 90% of all cases, and the prevalence is increasing globally. 1 About half of all deaths in patients with DM are due to cardiovascular disease, 1 the majority resulting from thrombotic events. 2 In addition, patients with DM have a 2‐ to 4‐fold higher risk of recurrent atherothrombotic events and vascular complications than those without DM. 2 Along with oxidative stress, inflam -Abstract Truncated-

Prognosis Impact of Diabetes in Elderly Women and Men with Non-ST Elevation Acute Coronary Syndrome

Early coronary revascularization among stable patients with non-ST-segment elevation acute coronary syndromes: the role of diabetes and age

An observational study of therapeutic procedures and in-hospital outcomes among patients admitted for acute myocardial infarction in Spain, 2016-2022: the role of diabetes mellitus

Early coronary revascularization among "stable" patients with non-ST-segment elevation acute coronary syndromes: the role of diabetes and age

The Effect of Diabetes on Prognosis Following Myocardial Infarction Treated with Primary Angioplasty and Potent Antiplatelet Therapy

Impact of gender on the long-term prognosis in acute STEMI patients undergoing primary percutaneous coronary intervention: analysis of 10-year all-comers registry

Diabetic patients with acute coronary syndromes in contemporary European registries: characteristics and outcomes

Association of risk factors on mortality in ST-elevation myocardial infarction patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies

Differences in 30-day complications and 1-year mortality by sex in patients with a first STEMI managed by the Codi IAM network between 2010 and 2016

Gender differences in prognosis and treatment in acute coronary syndrome at the coronary care unit

Sex and age significantly modulate cardiovascular disease presentation in type 2 diabetes: a large population-based cohort study

Clinical characteristics and long-term prognosis of female patients with acute coronary syndrome

Impact of Diabetes and Stroke on Long-Term Outcomes in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

Sex Differences in Epidemiology and Risk Factors of Acute Coronary Syndrome in Chinese Patients with Type 2 Diabetes: A Long-Term Prospective Cohort Study

Sex differences and sex steroids influence on the presentation and severity of cardiovascular autonomic neuropathy of patients with type 1 diabetes

Predictors of prolonged hospital stay and in-hospital mortality in female patients with acute myocardial infarction with specific reference to diabetes

Sex-dependent effect of socioeconomic status on cardiovascular event risk in a population-based cohort of patients with type 2 diabetes

Association of diabetes mellitus with clinical outcomes in patients with different coronary artery stenosis

Sex differences in long-term outcomes in older adults undergoing invasive treatment for non-ST elevation acute coronary syndrome: An ICON-1 sub-study

Can the in-hospital mortality gap between STEMI patients with and without diabetes mellitus be reduced? The cardio-renal hypothesis

Impact of Diabetes Mellitus on Antithrombotic Management Patterns and Long-Term Clinical Outcomes in Patients With Acute Coronary Syndrome: Insights From the EPICOR Asia Study.